12:00 AM
 | 
Jan 17, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Interferon-alpha: Pilot study

HBP said that its 18-patient Canadian trial showed that transdermal administration of interferon-alpha for two weeks produced a substantial reduction...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >